Wednesday, May 29, 2024
HomeHealthCorona Virus: Drap Approves Clinical Trials of Plasma Therapy, Ventilators

Corona Virus: Drap Approves Clinical Trials of Plasma Therapy, Ventilators

At the behest of the Prime Minister’s Assistant Specialist, Dr. Zafar Mirza, the Drug Regulatory Authority of Pakistan (DRAP) has allowed the manufacture of chloroquine raw materials locally to prevent corona virus.

Dr Zafar Mirza issued a statement saying that Drip has also allowed plasma therapy for the treatment of Covid-19 and clinical trials of ventilators manufactured in Pakistan.

It may be recalled that blood plasma was also obtained from Yahya Jaffrey, the first patient to be cured of plasma therapy for Covad19

Read Also:Pak army Shot down Indian drone entering Pakistani border

On the other hand, the ventilators developed by the Pakistan Engineering Council are being tested before use.

The statement also said that Drip had approved more than 50 companies to make hand sensitizers for 3 months.

Drip allowed the manufacture of sanitizers in accordance with the guidelines of the World Health Organization, which contained 80% alcohol (ethanol), 1.45% glycerol, and 0.125% hydrogen peroxide, which contained grit sanitizers.

It should be noted that Drip issued a notification a few days ago to ensure the supply of sanitizers due to the corona virus in the country.

The notification states that licensed companies will manufacture standard hand sanitizers according to the World Health Organization guidelines.

Dr Zafar Mirza had said that the government was making sure that all practical steps were taken to deal with the Corona virus.

It is thought that the Corona virus has infected 4,031 people in the country out of which 572 recovered and 63 lost their lives.

Read Also:Dow University experts discover resistant genetic changes in Corona pathway

What is Plasma Therapy?
For the treatment of plasma, the plasma isolated from the corona virus receives blood from it and transfers it to the anxious patient.

Plasma is actually a transparent part of the blood that is obtained upon separation of blood cells; plasma contains antibodies and other proteins.

Thus plasma transfers containing antibodies provide the ‘passive immune’ to the sick person to fight the disease, however the inactive immune process is usually effective for only a few weeks or months.

The important thing to do in this regard is that plasma donors need to have some tests before they can be diagnosed, such as the corona virus and coronary virus and other respiratory viruses when plasma donation, as well as hepatitis B. Virus, hepatitis C virus, HIV and syphilis test must come negative.

Plasma donors must be healthy for at least 10 days with sufficient amounts of specific antibodies to the corona virus.

Previous research on plasma transfers to diseases other than the corona virus indicates that this process is certainly not risky.

Read Also:Billionaire plans to distribute one million face masks through vending machines

This may result in side effects for the patient, including serious allergic reactions, lung injury and other blood disorders in patients suffering from other cardiovascular diseases.

Plasma therapy may provide promising results in the future, but at this time it is important to acknowledge that we are experiencing uncertainty, convalescent serum transfer is an experimental treatment.

- Advertisment -

Most Popular

Recent Comments